501 related articles for article (PubMed ID: 19925559)
21. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
Shan X; Vocadlo D; Krieger C
Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network.
Wei R; Bhattacharya A; Hamilton RT; Jernigan AL; Chaudhuri AR
Biochem Biophys Res Commun; 2013 Aug; 438(1):218-23. PubMed ID: 23886956
[TBL] [Abstract][Full Text] [Related]
23. Involvement of CHOP, an ER-stress apoptotic mediator, in both human sporadic ALS and ALS model mice.
Ito Y; Yamada M; Tanaka H; Aida K; Tsuruma K; Shimazawa M; Hozumi I; Inuzuka T; Takahashi H; Hara H
Neurobiol Dis; 2009 Dec; 36(3):470-6. PubMed ID: 19733664
[TBL] [Abstract][Full Text] [Related]
24. Zinc in the spinal cord of a mutant SOD1 mouse model of ALS.
Pamphlett R; Kum-Jew S
Neuroreport; 2003 Mar; 14(4):547-9. PubMed ID: 12657882
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of Vesicular Glutamate Transporter 2 and STAT3 Activation in the Spinal Cord of Mice Receiving 3,3'-Iminodipropionitrile.
Ohgomori T; Yamasaki R; Kira JI; Jinno S
Neurotox Res; 2018 May; 33(4):768-780. PubMed ID: 28965218
[TBL] [Abstract][Full Text] [Related]
26. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
[TBL] [Abstract][Full Text] [Related]
27. "Preconditioning" with latrepirdine, an adenosine 5'-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1(G93A) mice.
Coughlan KS; Mitchem MR; Hogg MC; Prehn JH
Neurobiol Aging; 2015 Feb; 36(2):1140-50. PubMed ID: 25443289
[TBL] [Abstract][Full Text] [Related]
28. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
[TBL] [Abstract][Full Text] [Related]
29. HtrA2/Omi-immunoreactive intraneuronal inclusions in the anterior horn of patients with sporadic and Cu/Zn superoxide dismutase (SOD1) mutant amyotrophic lateral sclerosis.
Kawamoto Y; Ito H; Kobayashi Y; Suzuki Y; Akiguchi I; Fujimura H; Sakoda S; Kusaka H; Hirano A; Takahashi R
Neuropathol Appl Neurobiol; 2010 Jun; 36(4):331-44. PubMed ID: 20202124
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analysis of sympathetic involvement in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis.
Kandinov B; Grigoriadis NC; Touloumi O; Drory VE; Offen D; Korczyn AD
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):424-33. PubMed ID: 23607704
[TBL] [Abstract][Full Text] [Related]
31. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
[TBL] [Abstract][Full Text] [Related]
32. A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS.
Nagano S; Takahashi Y; Yamamoto K; Masutani H; Fujiwara N; Urushitani M; Araki T
Hum Mol Genet; 2015 Jun; 24(12):3427-39. PubMed ID: 25762155
[TBL] [Abstract][Full Text] [Related]
33. Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis.
Cheroni C; Marino M; Tortarolo M; Veglianese P; De Biasi S; Fontana E; Zuccarello LV; Maynard CJ; Dantuma NP; Bendotti C
Hum Mol Genet; 2009 Jan; 18(1):82-96. PubMed ID: 18826962
[TBL] [Abstract][Full Text] [Related]
34. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
[TBL] [Abstract][Full Text] [Related]
35. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.
Schütz B; Reimann J; Dumitrescu-Ozimek L; Kappes-Horn K; Landreth GE; Schürmann B; Zimmer A; Heneka MT
J Neurosci; 2005 Aug; 25(34):7805-12. PubMed ID: 16120782
[TBL] [Abstract][Full Text] [Related]
36. AIF translocates to the nucleus in the spinal motor neurons in a mouse model of ALS.
Oh YK; Shin KS; Kang SJ
Neurosci Lett; 2006 Oct; 406(3):205-10. PubMed ID: 16916579
[TBL] [Abstract][Full Text] [Related]
37. MCP-1/CCR2 signaling-mediated astrocytosis is accelerated in a transgenic mouse model of SOD1-mutated familial ALS.
Kawaguchi-Niida M; Yamamoto T; Kato Y; Inose Y; Shibata N
Acta Neuropathol Commun; 2013 Jun; 1():21. PubMed ID: 24252211
[TBL] [Abstract][Full Text] [Related]
38. Survival motor neuron deficiency enhances progression in an amyotrophic lateral sclerosis mouse model.
Turner BJ; Parkinson NJ; Davies KE; Talbot K
Neurobiol Dis; 2009 Jun; 34(3):511-7. PubMed ID: 19332122
[TBL] [Abstract][Full Text] [Related]
39. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
40. GAB(A) receptors present higher affinity and modified subunit composition in spinal motor neurons from a genetic model of amyotrophic lateral sclerosis.
Carunchio I; Mollinari C; Pieri M; Merlo D; Zona C
Eur J Neurosci; 2008 Oct; 28(7):1275-85. PubMed ID: 18973555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
